PLANT-ORIGINATED HETEROCARPINE PROTEIN HAVING ANTI-CANCER PROPERTIES Russian patent published in 2008 - IPC A61K36/75 A61K38/16 A61K36/185 A61P35/00 

Abstract RU 2317097 C2

FIELD: medicine.

SUBSTANCE: disclosed is method for treatment of GHRH growth factor-associated cancer, in particular production of pharmaceutical agent for treatment of small cell carcinoma of lung or breast cancer. Claimed agent is obtained from plant originated protein produced from Pilocarpus heterofillus plant having anti-cancer properties, which binds to human growth hormone releasing hormone (GHRH).

EFFECT: agent of high anti-cancer activity.

5 cl, 2 ex, 4 dwg

Similar patents RU2317097C2

Title Year Author Number
PROTEIN FROM PILOCARPUS HETEROPHYLLUS PLANT AS ANTAGONIST OF HUMAN GROWTH HORMONE RELEASING FACTOR (GHRH), PROTEIN USES IN DRUG PRODUCING (VARIANTS), THERAPEUTICAL AGENT (VARIANTS), PHARMACEUTICAL COMPOSITION AGAINST GHRH ACTION, MONOCLONAL ANTIBODY, AND METHOD FOR PROTEIN ISOLATION 2002
  • Ferrandi Ehrik
  • Teng Beng Poon
  • Soier Kristin
  • Tjur'O Kristof
RU2305683C2
METHOD FOR MAKING RECOMBINANT HETEROCARPINE 2003
  • Ferrandi Ehrik
RU2359033C2
ALLOSTERIC ANTIBODIES AGAINST HUMAN HER3 NON COMPETITIVE FOR NEUREGULIN AND USE THEREOF 2013
  • Shard Terri
  • Gabori Nadezh
  • Larbure Kristel
  • Pelegren Andre
RU2704228C2
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION 2002
  • Ferrandi Ehrik
  • Kamara I Ferrer Khose-Antonio
  • Martine Zhan
  • Tjur'O Kristof
RU2307666C2
ANTI c-Met RECEPTOR PROTEIN ANTIBODIES 2011
  • Khultberg Anna
  • Sonders Majkl
  • De Khard Jokhannes
  • Festens Els
  • De Jonge Natali
  • Mikeli Paulo
  • Baziliko Kristina
  • Drajer Torsten
RU2608644C2
IMMUNOCYTOKINES BASED ON IL-15 AND IL-R[ALPHA] SUSHI DOMAIN 2012
  • Morisso Sebastyan Danel
  • Teppa Zheraldin
  • Zhak Yannik Loran Zhozef
  • Rober Bruno Zhilber Mark
  • De Martinoff Gi Lyuk Mishel
  • Beshar David
RU2644671C2
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6 2012
  • Sakhin Ugur
  • Tyurechi Ezlem
  • Kozlovski Mikhael
  • Valter Korden
  • Vel Shtefan
  • Krojtsberg Mariya
  • Khubner Bernd
  • Erdelyan Mikhael
  • Vajkhel Mikhael
RU2676731C2
BTN2-SPECIFIC ANTIBODIES AND USE THEREOF 2020
  • Foucher, Etienne
  • Cano, Carla
  • Le, Kieu Suong
  • Pasero, Christine
  • Olive, Daniel
RU2821703C2
USE OF MONOCLONAL ANTIBODIES SPECIFIC TO O-ACETYLATED FORM OF GANGLIOSIDE GD2 FOR TREATING CERTAIN FORMS OF CANCER 2007
  • Birkl' Stefan
  • Mjussini Zhan-Mari
  • Obri Zhak
  • Barbe Zhak
  • Shatal' Zhan-Fransua
RU2462476C2
NOVEL DUAL-TARGETED PROTEINS SPECIFICALLY BINDING TO DLL4 AND VEGF, AND USE THEREOF 2014
  • Li Ton Khon
  • Mun Kyun Tyuk
  • Tsoj Yu Pin
  • Kan Kyun Che
  • Kim Ton In
  • An Chin Khen
  • Yu Ven Kyu
  • Chon Chinvon
RU2648154C2

RU 2 317 097 C2

Authors

Ferrandi Ehrik

Teng Beng Poon

Soier Kristin

Tjur'O Kristof

Dates

2008-02-20Published

2003-08-25Filed